Table 1 Clinical characteristics of the study subjects according to the criteria of ATPIII
From: Effect of HDL composition and particle size on the resistance of HDL to the oxidation
| Â | Low-HDL-C | Control | P |
|---|---|---|---|
N (Men/Women) | 36 (25/11) | 41 (19/22) | 0.027 |
Current smoking (%) | 14 (40.0) | 9 (22.0) | 0.189 |
Coronary heart disease (%) | 12 (34.3) | 0 (0) | Â |
Age (years) | 43.7 ± 13.7 | 45.6 ± 12.7 | 0.802 |
Systolic blood pressure (mmHg) | 129 ± 18 | 128 ± 16 | 0.607 |
Diastolic blood pressure (mmHg) | 80 ± 11 | 81 ± 9 | 0.985 |
Body mass index (kg/m2) | 26.2 (23.9 - 29.0) | 23.7 (21.4 - 26.5) | 0.001 |
Waist circumference (cm) | 96.0 ± 10.8 | 84.7 ± 10.7 | 0.001 |
TC (mmol/l) | 4.22 (3.69 - 5.17) | 5.04 (4.31 - 5.60) | 0.003 |
TG (mmol/l) | 1.22 (1.02 - 1.62) | 0.85 (0.72 - 1.08) | < 0.0001 |
LDL-C (pmol/l) | 2.68 (2.15 - 3.53) | 2.79 (2.33 - 3.29) | 0.316 |
HDL-C (pmol/l) | 0.93 (0.81 - 0.99) | 1.62 (1.35 - 1.91) | < 0.0001 |
ApoA-I (mg/dl) | 110 (104 - 117) | 143 (129 - 159) | < 0.0001 |
ApoA-II (mg/dl) | 35 (29 - 40) | 37 (32 - 40) | 0.035 |
ApoB (mg/dl) | 96 (83 - 111) | 88 (78 - 106) | 0.657 |
PON1 activity (nmol/min/ml) | 155 (106-211) | 133 (92-265) | 0.614 |
hsCRP (mg/l) | 1.03 (0.51 - 2.91) | 0.46 (0.24 - 1.71) | 0.007 |